{"id":"W2057495794","doi":"10.1517/13543784.2011.565329","title":"Brivanib alaninate for cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; Medicine; Pharmacodynamics; Pharmacology; Cancer; Regorafenib; Angiogenesis; Colorectal cancer; Pharmacokinetics; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001889802,0.0004284642,0.00055224,0.000143037,0.0001267701,0.00003612833,0.0004976683,0.0004538141,0.0001343187],"category_scores_gemma":[0.0002063354,0.0003751281,0.0003988579,0.0001295654,0.0001890839,0.000005784905,0.0001563957,0.0002365163,0.0001113073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008424473,"about_ca_system_score_gemma":0.0009522178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004504685,"about_ca_topic_score_gemma":0.000002480983,"domain_scores_codex":[0.9980317,0.0001434094,0.0004256083,0.0007266381,0.0002943123,0.0003782898],"domain_scores_gemma":[0.9988444,0.00009412225,0.0002239979,0.0004456502,0.0001656401,0.0002262139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009726823,0.0001317251,0.00000697664,0.004495202,0.0004972711,7.657333e-7,0.0001964795,0.000005666738,0.0008472179,0.01915151,0.3313421,0.6432278],"study_design_scores_gemma":[0.00023802,0.0001940899,0.000004187026,0.0026444,0.000007412995,0.000004794415,0.000005072317,0.000005943354,0.001134722,0.0002970216,0.995056,0.0004083887],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008168098,0.9964209,0.00007750361,0.0001801827,0.0008223057,0.0009777214,0.0005110877,0.00002454298,0.0009775634],"genre_scores_gemma":[0.000006702943,0.9893199,0.0008278825,0.0005138509,0.001672288,0.001639253,0.004122655,0.0001207677,0.00177674],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6637138,"threshold_uncertainty_score":0.9998701,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1165598438133721,"score_gpt":0.4131320326980932,"score_spread":0.2965721888847211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}